The Minimal Energetic Requirement of Sustained Awareness after Brain Injury by Stender, Johan et al.
ReportThe Minimal Energetic Requirement of Sustained
Awareness after Brain InjuryHighlightsd Quantitative FDG-PET allows fine diagnosis and prognosis in
disorders of consciousness
d Level of consciousness after brain injury correlates with
whole-brain energetic state
d Emergence of awareness occurs above a sharply defined
brain energy metabolic boundaryStender et al., 2016, Current Biology 26, 1494–1499




Aurore Thibaut, Sune Darkner,





Stender et al. show that positron emission
tomographymeasurement of whole-brain
glucose metabolic state allows accurate
diagnosis and prediction of disorders of
consciousness. Recovery from the
unresponsive wakefulness condition
occurs above a sharply defined brain




ReportThe Minimal Energetic Requirement
of Sustained Awareness after Brain Injury
Johan Stender,1,2,5 Kristian Nygaard Mortensen,1,5 Aurore Thibaut,2 Sune Darkner,3 Steven Laureys,2 Albert Gjedde,1
and Ron Kupers1,4,*
1BRAINlab, Department of Neuroscience & Pharmacology, Panum Institute, University of Copenhagen, Nørre Allé 10, 2200 Copenhagen,
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Differentiation of the minimally conscious state
(MCS) and the unresponsive wakefulness syndrome
(UWS) is a persistent clinical challenge [1]. Based
on positron emission tomography (PET) studies
with [18F]-fluorodeoxyglucose (FDG) during sleep
and anesthesia, the global cerebral metabolic rate
of glucose has been proposed as an indicator of con-
sciousness [2, 3]. Likewise, FDG-PETmay contribute
to the clinical diagnosis of disorders of conscious-
ness (DOCs) [4, 5]. However, current methods are
non-quantitative and have important drawbacks
deriving from visually guided assessment of relative
changes in brain metabolism [4]. We here used
FDG-PET to measure resting state brain glucose
metabolism in 131 DOC patients to identify objective
quantitative metabolic indicators and predictors of
awareness. Quantitation of images was performed
by normalizing to extracerebral tissue. We show
that 42% of normal cortical activity represents the
minimal energetic requirement for the presence of
conscious awareness. Overall, the cerebral meta-
bolic rate accounted for the current level, or immi-
nent return, of awareness in 94% of the patient
population, suggesting a global energetic threshold
effect, associated with the reemergence of con-
sciousness after brain injury. Our data further re-
vealed that regional variations relative to the global
resting metabolic level reflect preservation of spe-
cific cognitive or sensory modules, such as vision
and language comprehension. These findings pro-
vide a simple and objective metabolic marker of
consciousness, which can readily be implemented
clinically. The direct correlation between brain meta-
bolism and behavior further suggests that DOCs can
fundamentally be understood as pathological neuro-
energetic conditions and provide a unifying physio-
logical basis for these syndromes.1494 Current Biology 26, 1494–1499, June 6, 2016 ª 2016 Elsevier LRESULTS
Positron emission tomography (PET) studies with [18F]-fluoro-
deoxyglucose (FDG) suggest that impaired consciousness
following brain injury is associated with overall brain metabolic
levels of 40%–60% of normal in conditions of coma, unrespon-
sive wakefulness syndrome (UWS), and minimally conscious
state (MCS) [5, 6]. Notwithstanding, relative regional variations
in metabolism correlate with the preservation of specific
behavioral or perceptual functions in MCS patients [7, 8], sup-
porting the claim that network activations cause local increases
in energy metabolism even in disorders of consciousness
(DOCs) [9]. Although assessment of relative cerebral metabolic
patterns with FDG-PET is a sensitive diagnostic tool in DOCs,
current methods are non-quantitative and inherently examiner
dependent. The development of diagnostic markers based on
quantitative measures of brain metabolism would enable a
more objective method for diagnosing DOCs, but they necessi-
tate the establishment of absolute energetic requirements of
awareness. However, no absolute cerebral metabolic criteria
exist that allow to distinguish betweenMCS and themore severe
UWS [1, 6], mainly because the presence of severe brain pathol-
ogy interferes with conventional non-invasive quantification
methods. We therefore employed a method of FDG uptake
normalization relative to extracerebral tissue, developed specif-
ically to accommodate difficulties in PET imaging of severe brain
injury patients. We hypothesized that global glucose metabolic
activity predicts the capacity for maintenance of conscious
awareness, while its regional variations reflect the integrity of
specific perceptual or cognitive functions. We also test the hy-
pothesis that the global cerebralmetabolic rate predicts thepres-
ervation or reattainment of consciousness at 1-year follow-up.
FDG-PET data at rest were acquired in 131 DOC patients and
28 healthy controls (Table 1). The patient population was split
into independent cohorts for derivation and validation of the
diagnostic model (Table S1). PET images were normalized to
signal intensity in the extracerebral cephalic tissue, which is un-
affected by brain injury and stable across subjects, thus yielding
a pseudo-quantitative cerebral metabolic index. To perform the
normalization, a reference distribution was calculated from the
extracerebral tissue intensity distributions of the 28 control
subjects. Each individual image of the study population wastd.
Table 1. Patient Demographics
Study Cohort CRS-R Diagnosis n Mean Age (Range, Y) Male
Time since Onset Mean
(Range, D) Traumatic Etiology
Derivation UWS 14 43 (22–73) 11 635 (7–2,884) 3
MCS 21 38 (15–66) 13 1,013 (13–3,336) 11
Validation UWS 35 48 (21–75) 20 622 (5–6,708) 10
MCS 44 41 (15–72) 28 1,299 (23–9,595) 22
EMCS 17 35 (16–62) 15 1,101 (143–5,080) 11
control 28 44 (20–70) 16 –
total 159 42 (15–75) 103 978 57subsequently normalized, by selecting a global scaling factor of
the image intensity such that the Jensen-Shannon divergence
between the reference distribution and the subject’s extracere-
bral intensity distribution was minimized [10]. Metabolic activity
after normalization was assigned an index value, with average
extracerebral metabolism in the reference distribution set to
one (see Supplemental Experimental Procedures). Brain images
were then first segmented into entire cerebral cortex of left and
right hemispheres and then further according to Brodmann areas
(BA) (Supplemental Experimental Procedures). We extracted the
mean cortical FDG uptake in each hemisphere and BA volumes
of interest (VOIs). We used the mean cortical metabolism of the
best preserved hemisphere (with highest mean cortical meta-
bolism prior to lesion masking) to classify between UWS and
MCS and predict outcome at 1-year follow-up, using receiver
operating characteristic (ROC) analysis.
Global Glucose Metabolism Rate as Diagnostic Marker
Mean cortical metabolic index was 7.59 ± 1.19 in healthy con-
trols, 2.88 ± 0.74 (38% of normal) in UWS, 4.23 ± 1.03 (56% of
normal) in MCS, and 4.76 ± 0.65 (63% of normal) in emergence
from MCS (EMCS). See Figure 1 for individual patient examples.
One-way ANOVA with Bonferroni correction for three compari-
sons showed that average metabolic rates were significantly
higher in MCS than UWS (p < 0.001) and in healthy controls
compared to EMCS (p < 0.001), but not in EMCS compared to
MCS (p = 0.098). Metabolic rates were not influenced by any
of a range of possible confounders, including age, etiology,
time since onset, and use of sedation during imaging (Supple-
mental Experimental Procedures).
Average cortical glucosemetabolism gave diagnostic discrim-
ination between MCS and UWS at an area under the ROC-curve
(AUC) of 0.84 (confidence interval [CI] 0.67–1) in the derivation
cohort and 0.91 (CI 0.84–0.98) in the validation cohort. The per-
formance of the classifier did not significantly differ between the
two cohorts (p = 0.45). The best classification rate in the deriva-
tion cohort was achieved at a metabolic index of 3.17 (41% of
normal activity; Figure 2), resulting in 89% correct classification
between UWS and MCS, with 95% sensitivity and 79% speci-
ficity to MCS, thus satisfying reasonable requirements for a clin-
ically useful diagnostic criterion. In the validation cohort, this
diagnostic threshold provided an 87% correct classification
rate between UWS and MCS, with 95% sensitivity and 77%
specificity to MCS. Post hoc inference suggested an optimal
metabolic cutoff at a metabolic index of 3.19 (42% of normal)
in the validation cohort; all patient classifications at this level re-mained unchanged compared to the derivation cohort threshold,
i.e., performance of the diagnostic model was similar in the deri-
vation and validation cohorts (Table 2).
Diagnostic accuracy with the above diagnostic criterion pro-
vided an AUC of 0.89 across the pooled cohort (CI 0.82–0.96).
There was 88% correct classification between MCS and UWS,
with 95% sensitivity and 78% specificity to MCS. Every EMCS
patient and healthy control was correctly identified as conscious.
Outcome Prediction
Outcome data at 1-year follow-up were obtained for 91% of the
patients. Demographic and clinical data did not differ between
patients with known outcome data and those without follow-up
data. Group discrimination by the metabolic criterion correctly
predicted 88% of all known patient outcomes, with 95% sensi-
tivity and 76% specificity to manifest consciousness at follow-
up (Figure 2; Table S3). A total of 11 UWS patients had brain
metabolism above the 41% diagnostic threshold. Of these, eight
had recovered consciousness at follow-up, and the remaining
three had died. One UWSpatient with sub-thresholdmetabolism
progressed to MCS on follow-up. Of the threeMCS patients with
sub-threshold metabolism, one died, while another one had no
change of clinical condition. The third patient was lost to
follow-up (Figure 2).
Regional Metabolic Activity
No specific regional drivers of the patients’ condition could be
identified, as the metabolic group differences were present
in all VOIs (Figure 3). Relative regional variability around the
mean activity was low, with interregional coefficients of variance
(SD/mean) of 6% in UWS, 13% in MCS, 14% in EMCS, and 15%
in controls.
FDG uptake in peristriate visual cortex (BA 18) had the highest
individual regional classification rate across the pooled cohort,
with an AUC of 0.90. This value, however, did not differ signifi-
cantly from the overall hemispheric classification rate (0.89;
p = 0.11). BA 18 classification rate (86%), sensitivity to MCS
(94%), and outcome prediction (80%) were slightly inferior to
classification by the entire hemisphere.
In order to test the hypothesis that regional variations relative
to the resting baseline metabolism can reflect preservation of
specific cognitive and sensory functions, we first normalized all
images to their global best-hemisphere mean (GM). Next, we
calculated Pearson correlation coefficients between visual
awareness, defined by the Coma Recovery Scale-Revised
(CRS-R) as the capacity for visual tracking, and GM normalizedCurrent Biology 26, 1494–1499, June 6, 2016 1495
Figure 1. Representative Individual FDG-
PET Examples
(A–C) UWS following subarachnoidal hemorrhage
(A), traumatic brain injury (B), and anoxic brain
injury (C), 8, 28, and 3 months after onset,
respectively.
(D–F) MCS following traumatic brain injury (D),
hemorrhagic stroke (E), and anoxic brain injury (F),
5 and 8 months and 3 weeks after onset, respec-
tively.
(G–I) EMCS following traumatic brain injury with
intracerebral hemorrhage (G), traumatic brain
injury (H), and anoxic brain injury (I), 106, 68, and
2 months after onset, respectively.
(J–L) Healthy controls.activity and absolute mean activity within visual cortex BAs 17,
18, and 19. Along the same line, we tested whether the ability
to respond to verbal commands correlated with GM-normalized
activity as well as absolute mean activity in areas commonly
associated with receptive aphasia, i.e., the left primary and sec-
ondary auditory cortices (BAs 20–22) and Wernicke’s area (BAs
39 and 40). OnlyMCS patients were included in this analysis. The
presence of visual responsiveness correlated with GM-normal-
ized metabolic rate in the visual cortex (r = 0.24, p = 0.028),
but not with absolute metabolic rates (r = 0.12, p = 0.29). Capac-
ity for command following correlated with both GM-normalized
and extracerebral normalized metabolic index in the auditory
and language-related areas (r = 0.49, p < 0.0001 and r = 0.39,
p = 0.002, respectively).
DISCUSSION
We tested the capacity of FDG-PET to diagnose the presence
and to predict the recovery of consciousness in brain-injured
subjects, using a novel measure of cerebral metabolic activity
based on extracerebral tissue normalization. The model accu-
racy was determined in two independent cohorts, using both
behavioral diagnosis and outcome at 1-year follow-up as refer-
ences. We show that our index of cerebral metabolic activity dif-
ferentiates accurately between UWS and MCS patients, hence1496 Current Biology 26, 1494–1499, June 6, 2016providing a strong diagnostic and prog-
nostic marker for chronic DOCs.
Global Cortical Metabolism as
Predictor of Consciousness
We hypothesized that the average cortical
metabolic activity in the most intact cere-
bral hemisphere can be used to classify
patients suffering from chronic DOCs. As
large lateralized cerebral lesions are prev-
alent in thispopulationandmayselectively
impair functioning of the affected hemi-
sphere [11], global mean metabolic activ-
ity is a poor representation of preserved
cerebral function. Since there is ample ev-
idence that conscious awareness can be
maintained with only one hemisphere
[12, 13], we reasoned that an FDG-PET in-dex of glucose metabolism of the least injured cortical hemi-
sphere would be a better indicator of consciousness than is
whole-brain cortical activity. This prediction was confirmed by
our finding that mean glucose metabolism index in the best pre-
served hemisphere is an accurate subject-level diagnostic
marker and that no individual brain region provided better classi-
fication than the average cortical signal. The diagnostic perfor-
mance of this method was equally good in the derivation and
validation samples, indicating that the method is valid across in-
dependent cohorts. ROC of the classification between MCS and
UWS gave a common ‘‘optimal’’ diagnostic threshold of 42% of
normal metabolic activity, resulting in excellent sensitivity and
adequate specificity to MCS. Moreover, all EMCS patients and
healthy controls were correctly identified as being conscious.
We conclude that this FDG-PET diagnostic threshold provides
reliable differentiation between conscious and unconscious sub-
jects, with a good balance between type I and type II error risks.
The FDG metabolic index in the MCS groups largely overlap-
ped with that in EMCS and was in a few cases within the range
of healthy control values. This is not surprising given the fluctu-
ating severity of MCS. Also, the mean cortical glucose metabolic
index was not dependent on etiology or any of the potential
confounders such as age or gender. Together, these results sug-
gest that cerebral glucose metabolism is strongly linked to the
expression of consciousness, irrespective of cause of injury
Figure 2. Global Brain Glucose Metabolism
Distribution of quantified cortical metabolic values
(best preserved hemisphere) for all individual
subjects in the pooled cohort. The dashed line
marks the optimal diagnostic cutoff between pa-
tients in UWS and MCS. Horizontal lines mark the
group averages. Metabolic values are indicated as
a unitless index, with average activity in the scaling
reference area (extracerebral tissue) set to 1. See
also Tables S1–S3.and time since onset. Cerebral metabolic activity also accurately
predicted the level of consciousness at 1-year follow-up. Group
separation along the 42% diagnostic threshold had an overall
88% correct outcome prediction in the mixed group of MCS
and UWS patients. This is all the more compelling considering
that the relatively high mortality rate over the long follow-up
period may have attenuated the predictive power. Nonetheless,
our method correctly predicted eight out of ten recoveries
among UWS patients.
The specificity of the metabolic level to both diagnosis and
prognosis suggests that the classification threshold represents
the minimal energetic requirements of sustained awareness.
Notably, our results indicate that transition between the uncon-
scious and conscious states takes place above a sharply defined
global (or hemispheric) metabolic boundary and point to a global
energetic threshold effect, which enables the reemergence of
consciousness after brain injury. This finding is consistent with
previous propositions [2, 14] that consciousness cannot solely
be attributed to activity in specific networks or areas but is asso-
ciated with a whole-brain high energetic state. As such, pre-
servedglucosemetabolic rate in at least onehemisphere appears









Derivation 0.84 (CI 0.67–1) 0.89 3.17
Validation 0.91 (0.84–0.98) 0.88 3.19
Pooled 0.89 (CI 0.82–0.96) 0.88 3.18
Currentter brain injury. Overall, the cortical meta-
bolic level accounted for the actual state
or imminent recovery in 94% of the UWS
and MCS patients. This direct correlation
between brain metabolism and behavior
indicates that global reduction of cortical
neuronal work is a defining characteristic
of DOCs andmay provide a unifying phys-
iological basis for these syndromes.
Significance of Regional Metabolic
Variations Relative to the Cortical
Hemispheric Average
All subjects had regional cerebral meta-
bolic variations relative to the globalmean signal. Brain activation in response to specific sensory or
cognitive tasks can cause 10%–30% local increases in the
magnitude of cortical glucose metabolism relative to resting
baseline [9]. We reasoned that regions of relatively spared
glucosemetabolism in our patient groups reflect sustained activ-
ity in support of specific cognitive or sensory functions. Thus,
while all conscious groups showed interregional variations with
a coefficient of variance of 13%–15%, i.e., within the range of
the proposedmodular activation effect, glucosemetabolic activ-
ity was nearly uniform across all cortical regions in UWSpatients.
Regional metabolic patterns in the MCS and EMCS groups were
qualitatively similar to that observed in normal subjects, i.e., rela-
tively higher in primary sensorimotor areas, although the peaks
had lower absolute values and less variability. This pattern differs
substantially from that of UWS patients, which was character-
ized by overall low FDG uptake, and is accordingly associated
with capacity for consciousness. Our previous findings of rela-
tively lowered frontoparietal metabolism in UWS patients [4, 6]
can therefore be explained by the absence of regional activa-
tions rather than by a specific decline or injury to these areas.
MCS patients with absence of overt visual awareness had
relatively lower activity in visual cortex, further supporting the
functional relevance of regional variations in residual meta-
bolism. Conversely, these patients’ ability of command respond-
ing correlated with FDG uptake in auditory and language areas.
Notably, these correlations emerged or became stronger after
global mean scaling and therefore indicate relative preservation
of energy metabolism in regions subserving preserved cognitive
domains. Thus, with the global effect accounted for, specific
regional differences between unconscious and conscious pa-
tients largely appear to reflect preserved sensory or cognitive
capacity.Biology 26, 1494–1499, June 6, 2016 1497
Figure 3. Regional Variations in Brain
Glucose Metabolism
Average quantitative metabolic values by Brod-
mann area, for each diagnostic group, are repre-
sented on overlapping bars. Very small regions
(<100 voxels) were excluded from the analysis.Clinical Implementation
The results indicate that assessment of cortical glucose meta-
bolism by non-invasive FDG-PET is a reliable method for detect-
ing the presence of, or potential for, consciousness and
cognition after brain injury. The method is objective and compu-
tationally simple and provides easily interpretable results.
Overall, this represents an important improvement to current
non-quantitative diagnostic approaches with FDG-PET.
Study Limitations
We here assume a direct correlation between the metabolic in-
dex and actual neuronal work. The accuracy of this assumption
should be evaluated in further studies (but see Supplemental
Experimental Procedures for supporting data). The present
study was cross-sectional and did not allow evaluation of rapid
evolution of metabolic status or their potential effects on clinical
outcome. While we cannot attribute causation in the link be-
tween high brain glucosemetabolism and conscious awareness,
the FDG-PET literature on anesthesia [2, 3] suggests causation.
We could not assess possible contributions of cerebral morbidity
prior to injury, nor did we consider the normal declines in cerebral
metabolism between childhood and adolescence [15] and
further into old age [16].
The method requires high standards in image quality and
registration. Current atlas-based approaches cannot precisely
describe subcortical changes in severely deformed brains [17].
Investigations of subcortical metabolic drivers, such as tha-
lamo-cortical [18] or mesocircuit loops [19], therefore fall outside
the scope of this study.
Conclusions
Hemispheric preservation of brain glucose metabolism predicts
the presence, or potential for recovery, of consciousness in brain
injury patients. Loci of regionally preserved metabolism sub-
serve specific cognitive and sensory functions. The threshold
of 42% of normal cortical hemispheric metabolic activity repre-
sents the minimal energetic requirement predictive of regaining
consciousness. FDG-PET thus constitutes a strong diagnostic
and prognostic marker in DOC arising from brain injury, irrespec-
tive of its pathogenesis.
EXPERIMENTAL PROCEDURES
The study was approved by the Ethics Committee of the University Hospital of
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Figure S1: Template and segmentation masks. Related to Methods. (A) Template image. (B) Cortical 





Figure S2: Reference distribution creation workflow. Related to Methods. (A) All distributions are fitted to a 
single-subject reference distribution, and averaged to the intermediate reference distribution. (B) Fitting to 



















Figure S3: (A) Examples of extracerebral distributions after mean normalization (top) and distribution fitting 
(bottom). Related to Methods. (B) Spatial distribution of the 5th lowest (blue) and highest (yellow) percentile 






Figure S4: Deming regression of average cortical metabolic values in 26 healthy controls, obtained with 

































Table S2: Effects of lesion masking. Related to Figure 2.   
 
Diagnosis Average highest 
hemispheric metabolic index 
before lesion masking  
Average highest 
hemispheric metabolic 
index after lesion masking  
Difference between 
results before and after 
masking (p-value) 
UWS 2.880  2.882  0.987 
MCS 4.220 4.234 0.944 




Table S3: 1-year outcomes of UWS and MCS patients. Related to Figure 2. 
 





31 unconscious (18 dead) 
5 unknown 
1 conscious 




3 unconscious (3 dead) 
 
51 conscious 






Measure Cohort p-value 
Age  Pooled 0.984 
Etiology   Pooled 0.123 
Time since onset  Pooled 0.056 
Age Derivation 0.634 
Traumatic Derivation 0.786 
Time since onset Derivation 0.257 
Blood sugar  Derivation 0.626 
Weight  Derivation 0.545 
Dose  Derivation 0.810 
Delay  Derivation 0.601 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
Data transparency 
Many of the patients were included in previous studies cited by this report. The derivation cohort of the 
present study was obtained from subjects included in [S1]. The validation cohort comprised patients included 
in [S1, S2] who underwent FDG-PET after 2010, as well as a number of more recently examined subjects. In 
total, 35 patients were included in [S1] and 75 in [S2].  
Supplemental methods 
Behavioral diagnosis 
The Coma Recovery Scale- Revised (CRS-R) is a sensitive diagnostic tool that is routinely used to 
discriminate among patients with very low levels of awareness [S3, S4]. Experienced neuropsychologists 
conducted daily CRS-R assessments over five consecutive days. The final diagnosis was determined by the 
best response obtained in the five assessments.  
Outcome assessment 
Twelve months following the initial CRS-R evaluation, long-term clinical outcome was assessed using the 
Glasgow Outcome Scale – Extended (GOS-E) [S5]. As we sought to predict the recovery of consciousness, 
the outcomes were ultimately stratified into the categories unconscious (GOS-E ≤ 2) or conscious (GOS-E > 
2). Outcome evaluation was obtained from the patients’ medical reports. The referring physician provided 
additional data when necessary.  
PET acquisition 
We acquired the PET data with a Gemini PET-CT (Philips Medical Systems) at the Liège University 
Hospital. Patients and controls were in a darkened and quiet room while receiving a bolus intravenous 
injection of FDG (185 - 370 MBq). After a 30-minute uptake phase, we recorded a single 12-minute emission 
frame. The images were corrected for attenuation using X-ray computed tomography (CT), as well as for 
random scatter and physical decay.  
PET registration and template creation 
PET images were registered to a population-specific PET template created separately for the patient (UWS 
and MCS combined) and control groups as described previously [S6]. In brief, all PET-FDG scans were first 
registered to the H2O-PET-template provided in the SPM-software package [S6, S7], using an affine 
transformation, and then averaged to create an initial template. All individual PET-FDG images were 
registered to this template using affine and non-linear registration steps and then averaged, creating the next 
intermediate template. Registration to the previous intermediate template, and averaging, were repeated four 
times, resulting in the two final PET templates. 
Segmentation and parcellation 
We segmented the PET templates to left and right entire cerebral cortices, and extracerebral tissue, the latter 
being defined as tissue outside of the default SPM brain mask, with radioactivity concentration > 50% of the 
image wide mean activity. The bilateral cortical masks were then divided into volumes of interest (VOIs) for 
each Brodmann area (BA) using the brain atlas in MRIcron [S8]. (Figure S1). Individual PET-images were 
registered to the appropriate template (for patients or healthy controls) with affine and non-linear registration 
steps; hemisphere and VOI masks were subsequently transformed to individual PET-space using the inverse 
transformation. Nine VOIs contained less than 100 voxels after transformation and were omitted from further 
analysis. 
Extracerebral tissue normalization 
The gold standard for quantification of cerebral metabolic rate for glucose entails fitting a dynamic FDG-PET 
recording relative to the measured arterial input function; this requirement can hardly be met in routine 
studies, and invasive arterial catheterization is rarely employed in unresponsive patients. Commonly, FDG 
uptake is normalized to that in some reference brain region, assumed to be unaffected by treatment or medical 
condition [S9]. However, this assumption is clearly violated in brain-injured patients who present with global 
metabolic deficits and/or extensive lesions. An alternative approach, previously employed in [S1], substitutes 
the individual arterial tracer curve with a standardized uptake curve obtained from a group of healthy 
volunteers. This approach assumes comparable uptake curves among subjects, a condition which may not be 
met, particularly in a population with heterogeneous brain-injuries. Also, substitution of a key physiological 
variable will invariably bias individual modeling results to some degree. Given these considerations, we 
developed a method for normalization of brain uptake to an extracerebral tissue, rather than to a brain 
reference region.   
 
To perform the extracerebral normalization, a reference distribution was calculated from the 28 control 
subjects. All extracerebral intensity distributions of the control images were normalized to a randomly 
selected subject's extracerebral intensity distribution, by selecting a global scaling factor of the intensities 
such that the Jensen–Shannon divergence (JSD) between the distributions was minimized. A new distribution 
was then created as the average of the normalized distributions (Figure S1A). The process was iterated with 
the new average distribution as reference (Figure S1B-C) until a JSD between two subsequent reference 
distributions of less than 10-6 was obtained. Each individual image of the study population was subsequently 
normalized, by scaling the image intensities to minimize the JSD between the reference distribution and the 
subject's extracerebral distribution. The discrete distributions were approximated using 500 bin histograms, 
and the JSD minimized using the Nelder-Mead simplex minimization-method [S10]. Metabolic activity after 
normalization was assigned an index value, with average extracerebral metabolism in the reference 
distribution set to one (Figure S2). This approach assumes comparable individual glucose uptake in the 
extracerebral cranial volume, largely comprising bone, skin, blood, muscles and mucosa. Metabolic activity in 
these tissues is unaffected by brain pathology, rather uniform and of low inter-individual variability, and 
seemingly insensitive to physiological confounders [S11]. While this extracerebral signal might increase 
focally with muscle activity or inflammation, our procedure minimized the divergence between extracerebral 
intensities. The presence of divergent regions would elongate the tail of the voxelwise-distribution of FDG-
uptake, but not otherwise affect distribution shape. As such, we contend that the extracerebral tissue signal is 
a valid normalization reference, and is in principle analogous to other methods for non-invasive quantitation 
[S12, S13]. Indeed, we found that hemispheric glucose metabolism was reduced to 37% in UWS, 56% in 
MCS, and 63% in EMCS groups, findings which match with previous results using more invasive 
quantitation [S1, S14, S15]. The low variability of cerebral FDG uptake among our healthy controls is also in 
line with previous findings [S16, S17]. Taken together, our extracerebral normalization results thus have face 
validity and are robust to the lack of a suitable cerebral reference region in these patients.  
 
Control for normalization and physiological confounders 
The normalization procedure assumes comparable shapes of the extracerebral intensity distribution across 
subjects. The normalization is primarily driven by the peak of the distribution curve, and thus requires a 
unimodal intensity distribution within the reference mask. Individual curve inspection indicated that the 
distribution peak was primarily driven by the vascular signal. Contributions from muscle and unvascularized 
volumes, in particular skull and cerebrospinal fluid, comprised a minor fraction of the full distribution 
volume. Differences in head-shape, or anatomical volume included in the image window did not affect curve 
shapes significantly (Figure S3). 
To control for physiological confounders, contributions of age, weight, blood glucose levels, tracer dose and 
circulation time were tested in separate general linear models, with mean hemisphere uptake as dependent 
variable, and subject diagnosis as covariant. We further tested the stability of the normalization procedure to a 
priori parameters; histogram bin count and choice of initial subject for RD creation. To this end, we measured 
the average coefficient of variation (CV; std/mean) of global cerebral mean metabolism after normalization 
for all patients across different bin counts (100, 300, 600, 900), and different initial subject (all control 
subjects).  
None of the tested physiological confounders correlated significantly with metabolism (Table S1). 
Differences in bin size provided negligible differences in final result of ED normalization (average CV: 
2.2%). Similarly, the choice of the first subject in the creation of the RD had minor influence on the results 
(average CV: 3% across all possible initial subjects).  
 
Correspondence between the metabolic index and actual rate of glucose consumption 
To test the correspondence of the derived metabolic index to actual glucose metabolism, we further performed 
a Deming-correlation [S18] between average cortical metabolic values obtained in healthy volunteers, using 
Sokoloff-modeling with a standard arterial input function, and extracerebral normalization (Figure S4). 
Quantitation with a standard arterial input-function is generally accepted as a valid approximation of true 
kinetic modeling, although with some error at the individual level. Despite expected noise in both datasets, 
this analysis showed high correspondence (r=0.68, p=0.0002) between the extracerebral normalization results 
and the approximated absolute metabolic rates of glucose. Overall, the above indicates that our findings are 
not specific to the normalization method, but could in principle be derived with any FDG-PET quantitation 
method, as long as the challenges of imaging in the severely injured brain are properly addressed.  
 
Effects of lesion masking 
For each patient group, we assessed the influence of focal lesions on the mean cortical FDG index by 
comparing its average metabolism with and without lesion masking, using the Wilcoxon rank-sum test. We 
controlled for confounds from age, gender, etiology, and time since onset, using separate general linear 
models with mean metabolism in the better hemisphere as dependent variable, and subject diagnosis as 
covariant. Lesion masks were required in 25 subjects, comprising on average 2% (range 0.5-15%) of the total 
volume in the best cortical hemisphere mask. Inclusion of the lesion masks did not significantly alter group 
mean cortical metabolism results or classifier performance (Table S2).  
 
Influence of anesthesia during the imaging protocol 
All patients were in a medically stable condition; none were intubated or in pharmacological coma during the 
behavioral examinations or at the start of the image acquisition. To avoid motion artifacts, a number of 
patients required sedation during the tomography. Sedation was in all cases performed with propofol, and 
initiated after tracer circulation. As the PET image predominantly reflects metabolic activity during the tracer 
circulation period, sedation during the tomography has negligible effects on the calculated FDG-uptake.   
 
Corroborating this notion, we assessed the correlation between sedation during tomography and the calculated 
metabolic index with a linear regression, using diagnostic group as covariant. We here found no significant 
interaction between sedation and the metabolic index across the entire cohort (p=0.186). In total, only 9/49 
(18%) UWS patients were sedated, compared to 27/65 (42%) and 8/17 (47%) of MCS and EMCS patients, 
respectively. 
 
Within the UWS subgroup, the average metabolic index was significantly higher among sedated (3.49 ±0.99) 
than unsedated (2.75 ±0.61) subjects (p=0.003). We found no significant differences in average metabolic 
index between sedated (4.20 ±0.98) and unsedated (4.26 ±1.10) MCS patients (p=0.83). Likewise, we found 
no significant differences in average metabolic index between sedated (4.69 ±0.51) and unsedated (4.83 
±0.82) EMCS patients (p=0.65). We thus conclude that sedation during the imaging session is not a driving 
factor of the current results.  
 
Software packages  
Image registration and template creation were performed with Advanced Normalization Tools (ANTs version 
2.0.3). Image processing and statistical analysis were performed in Matlab (Matlab 8.4 Mathworks Inc., 
Natick, Massachusetts) and STATA 12 (StataCorp. 2011. Stata Statistical Software: Release 12. College 
Station, TX: StataCorp LP), respectively. Data was used from the SPM8 Matlab toolbox (Statistical 
Parametric Mapping version 8, Wellcome Trust Centre for Neuroimaging, University of London) and the 















[S1] Stender, J., Kupers, R., Rodell, A., Thibaut, A., Chatelle, C., Bruno, M.-A., Gejl, M., Bernard, C., 
Hustinx, R., Laureys, S., et al. (2015). Quantitative rates of brain glucose metabolism distinguish 
minimally conscious from vegetative state patients. J. Cereb. Blood Flow Metab. 35, 58-65. 
 
[S2] Stender, J., Gosseries, O., Bruno, M.-A., Charland-Verville, V., Vanhaudenhuyse, A., Demertzi, A., 
Chatelle, C., Thonnard, M., Thibaut, A., Heine, L., et al. (2014). Diagnostic precision of PET 
imaging and functional MRI in disorders of consciousness: a clinical validation study. Lancet 9;384, 
514–522. 
 
[S3] Hirschberg, R., and Giacino, J. T. (2011). The vegetative and minimally conscious states: diagnosis, 
prognosis and treatment. Neurol. Clin. 29, 773–786. 
 
[S4] Giacino, J. T., Kalmar, K., and Whyte, J. (2004). The JFK Coma Recovery Scale-Revised: 
measurement characteristics and diagnostic utility. Arch. Phys. Med. Rehabil. 85, 2020–2029. 
 
[S5] Teasdale, G. M., Pettigrew, L. E., Wilson, J. T., Murray, G., and Jennett, B. (1998). Analyzing 
outcome of treatment of severe head injury: a review and update on advancing the use of the 
Glasgow Outcome Scale. J. Neurotrauma 15, 587–597. 
 
[S6] Avants, B. B., Tustison, N. J., Song, G., Cook, P. A., Klein, A., and Gee, J. C. (2011). A 
reproducible evaluation of ANTs similarity metric performance in 
  brain image registration. Neuroimage 54, 2033–2044.  
 
[S7] Phillips, C. L., Bruno, M.-A., Maquet, P., Boly, M., Noirhomme, Q., Schnakers, C., 
Vanhaudenhuyse, A., Bonjean, M., Hustinx, R., Moonen, G., et al. (2011). “Relevance vector 
machine” consciousness classifier applied to cerebral metabolism of vegetative and locked-in 
patients. Neuroimage 56, 797–808. 
 
[S8] Rorden, C., and Brett, M. (2000). Stereotaxic display of brain lesions. Behav. Neurol. 12, 191–200. 
 
[S9] Borghammer, P., Jonsdottir, K. Y., Cumming, P., Ostergaard, K., Vang, K., Ashkanian, M., Vafaee, 
M., Iversen, P., and Gjedde, A. (2008). Normalization in PET group comparison studies--the 
importance of a valid reference region. Neuroimage 40, 529–540. 
 
[S10] Lin, J. H. (1991). Divergence Measures Based on the Shannon Entropy. IEEE Trans. Inf. Theory 37, 
145–151. 
 
[S11] Lindholm, H., Brolin, F., Jonsson, C., and Jacobsson, H. (2012). The relation between the blood 
glucose level and the FDG uptake of tissues at normal PET examinations. EJNMMI Res. 3, 50–50. 
 
[S12] Backes, H., Walberer, M., Endepols, H., Neumaier, B., Graf, R., Wienhard, K., and Mies, G. (2011). 
Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using 
(18)F-FDG PET: application to focal cerebral ischemia. J. Nucl. Med. 52, 1252–1260. 
 
[S13] Chen, K., Chen, X., Renaut, R., Alexander, G. E., Bandy, D., Guo, H., and Reiman, E. M. (2007). 
Characterization of the image-derived carotid artery input function using independent component 
analysis for the quantitation of [18F] fluorodeoxyglucose positron emission tomography images. 
Phys. Med. Biol. 52, 7055–7071. 
 
[S14] Laureys, S., Owen, A. M., and Schiff, N. D. (2004). Brain function in coma, vegetative state, and 
related disorders. Lancet Neurol. 3, 537–546. 
 
[S15] Rudolf, J., Ghaemi, M., Ghaemi, M., Haupt, W. F., Szelies, B., and Heiss, W. D. (1999). Cerebral 
glucose metabolism in acute and persistent vegetative state. J. Neurosurg. Anesthesiol. 11, 17–24. 
 
[S16] Kuwabara, H., and Gjedde, A. (1991). Measurements of glucose phosphorylation with FDG and PET 
are not reduced by dephosphorylation of FDG-6-phosphate. J. Nucl. Med. 32, 692–698. 
 
[S17] Schlünzen, L., Vafaee, M. S., Cold, G. E., Rasmussen, M., Nielsen, J. F., and Gjedde, A. (2004). 
Effects of subanaesthetic and anaesthetic doses of sevoflurane on regional cerebral blood flow in 
healthy volunteers. A positron emission tomographic study. Acta Anaesthesiol. Scand. 48, 1268–
1276. 
 
[S18] Linnet K. (1993) Evaluation of Regression Procedures for Methods Comparison Studies. Clin Chem. 
39:424–32. 
 
